Neuroscience

Stanford traces brain aging to stalled protein factories inside cells

Stanford scientists are tracing brain aging to a very basic failure: ribosomes, the machines that read genetic instructions and build proteins, begin to stall over time.

Cambridge organoids turn 'irreversible' nerve damage into a question of switches

Miniature brain-and-spinal-cord systems grown in the lab suggest that what is often treated as irreversible nerve damage may still have a biological switch.

Asia-Pacific tests AI as a wider net for hidden lung cancer

In Asia-Pacific lung cancer screening, AI is no longer a futuristic add-on but a practical attempt to catch tumors that escape old risk lists.

Alzheimer’s Leaves a Midlife Trace Before Dementia Becomes Visible

A new analysis suggests Alzheimer’s pathology can be detected in midlife brains before dementia and before a dramatic loss of daily function.

Oulu finds a cancer lead in anemia drugs already familiar to hospitals

Drugs routinely used against anemia are now showing up as an unexpected oncology signal, but for now as a laboratory lead rather than a finished treatment recommendation.

University of Pittsburgh scan pushes Alzheimer’s diagnosis before symptoms

A new brain imaging method targets one of Alzheimer's most important biological traces before symptoms appear, making it clinically important because the treatment window begins before visible cognitive decline.

Anderson Cancer Center maps tumor immune strongholds that may guide therapy

A new AI-powered spatial atlas does not just ask whether a tumor carries an immune signature, but where that signature sits, how mature it is and what it may say about the course of disease.

University of Tartu sharpens the map between genes, glucose and cholesterol

One of the largest analyses of human metabolism to date shows that rare DNA variants can expose links that standard genetic studies often miss.

Cambridge’s lab-grown nerve circuit tests the edge of irreversible damage

Cambridge scientists have grown a lab model of the brain-spinal cord connection and used it to show that damage long treated as irreversible may not always be a one-way injury.

Titanium particles change the story of dental implant infections

A dental implant is not just a passive screw in bone once peri-implantitis develops: a new report suggests titanium particles may be part of the reason antibiotics often fail.

Dr. Tracy M. Liang’s AI Braces map treatment before the first tooth moves

SMILE-FX Orthodontic Studio in Miramar has introduced AI Braces as a local, data-informed attempt to make orthodontic planning more predictable before teeth begin to move.

Columbia targets Sirtuin 1 in the prostate cancer that escapes treatment fastest

Neuroendocrine prostate cancer is a rare, hard and clinically difficult form of the disease, and a new Columbia study now ties it to one clear molecular lever: Sirtuin 1.

Oura Ring 5 turns the quiet smart ring into an AI health radar

Oura Ring 5 is not just another smaller wearable, but an attempt to turn the smart ring into a quieter, always-on health monitoring layer.

Vanderbilt Health asks what Alzheimer’s scans miss in dementia care

A new Vanderbilt Health-led study warns that dementia may not look the same on brain scans across communities, with direct consequences for diagnosis and treatment access.

ReDLat2 moves dementia research upstream, before the diagnosis becomes visible

ReDLat2 puts dementia in a space where genetics, the exposome and biological clocks have to be read together, not as three separate notes in a medical file.

Parkinson’s research finds a new target in the immune chain of brain damage

New research places the protein GPNMB at the center of how Parkinson’s disease may spread through the brain, and where that process might be interrupted.

ScienceDaily: an arthritis drug opens an immune clue in hard-to-treat depression

A new therapeutic idea for depression starts not with serotonin or dopamine, but with the possibility that inflammatory immune signaling may keep symptoms locked in place for some patients.

Google Search signals allegedly became a million-dollar edge on Polymarket

The allegations against Michele Spagnuolo show how quickly internal data from a major technology platform can become a market edge.

Stem-cell heart patch boosted pumping in weakened hearts

A stem-cell-based heart patch has shown an early clinical signal in one of cardiology’s hardest corners: advanced heart failure.

After a trial miss, Verge Labs makes patient matching the real AI drug test

Verge Labs has shifted its center of gravity from AI-powered drug hunting to a more practical neuroscience question: how to identify, earlier, which patients a brain drug is most likely to help.

Orbbec’s warning to robotics: better AI cannot fix badly calibrated eyes

The problem with robotic vision is not only that AI fails to understand a scene, but that robots often feed it messy, poorly aligned data from the real world.

A SpaceX listing would price orbit for Europe, not solve its space gap

If SpaceX really moves toward the public markets, Europe’s space sector will not just be watching someone else’s valuation; it will be testing its own investment story.

Guava shifts the anemia question to absorption, not just iron pills

Guava juice is not an anemia cure, but a new review suggests it could be a cheap nutritional amplifier for iron therapy where low blood levels remain a public-health burden.

Schwann cells point to an earlier pain target in neurofibromatosis type 1

Pain in neurofibromatosis type 1 may not begin with a tumor on the nerve, but earlier, in disrupted signaling between Schwann cells and sensory nerves.

Japan’s vitamin K chemistry points to neuron repair, not a dementia cure

Japanese scientists have opened a sharper route toward brain regeneration: chemically enhanced vitamin K compounds that push neural stem cells toward neurons more strongly in the lab.

FDA gives Modius a medical lane for post-traumatic stress care

The FDA’s de novo clearance for Modius is not just another wearable-device headline, but a regulatory signal that neuromodulation is moving deeper into PTSD care.

Texas A&M’s brain-aging spray is promising because it is still only a mouse signal

The Texas A&M nasal spray sounds like a major medical story, but for now it should be read as a promising preclinical signal, not a ready dementia treatment.

FDA’s lesson for rare disease trials: the wrong measure can hide a drug signal

In rare disease trials, statistics cannot rescue a poorly chosen endpoint: if the COA misses what actually changes, the treatment signal can disappear into noise.

BepiColombo is late, but Mercury still has a mission worth waiting for

BepiColombo now has a concrete Mercury arrival date: November 21, eleven months later than expected, but still within the window for the mission to do science.

taVNS tests the vagus nerve where rehab matters: during movement

Vagus nerve stimulation is no longer only a story about implants and autonomic control: researchers are now trying to place it more precisely inside movement rehabilitation.

Pulse oximeters and the FDA warning: one oxygen number can delay care for Black patients

The problem with pulse oximeters is not one number on a screen, but the way that number can decide who gets attention, follow-up testing and faster care.

McGill removes the brakes from natural killer cells against aggressive tumors

Researchers at McGill University have shown how natural killer cells can be temporarily redirected into a stronger attack on tumors that usually survive immune pressure.

Cat tumors widen the cancer map alongside the National Cancer Institute

A large genetic study of feline tumors turns house cats from a poorly mapped patient population into a serious model for understanding human cancer.

Hailo cools the humanoid race: physical AI has to win the boring jobs first

The useful point in Hailo’s argument is not that humanoids disappear, but that physical AI first has to prove itself in machines that do one job reliably, locally and cheaply.

IDOL emerges as a new Alzheimer’s target

New research shifts part of the Alzheimer’s conversation from simply clearing amyloid to IDOL, an enzyme that may regulate plaques, APOE and neuronal communication.

ABT-263 sped wound healing in aged mouse skin

Topical ABT-263 accelerated wound closure in aged mice and boosted gene signals tied to collagen production and tissue regeneration.

A mouse Alzheimer’s therapy targets the brain’s cleanup system

A new mouse study suggests Alzheimer’s pathology may not have to be attacked only inside neurons, but also through repair of the brain’s cleanup system.

A home robot that cannot treat Parkinson's but may restore the rhythm of a day

MYC, long known for driving tumor growth, may also move directly into damaged DNA and help cancer cells repair the very injuries caused by therapy.

Memory returned in dementia-model mice after scientists boosted neurons’ power supply

New research in Nature Neuroscience pushes mitochondria from the background of neurodegeneration into the foreground: failure in the brain’s energy machinery may not merely follow disease, but help trigger cognitive decline early.

Serotonin raises a hard question for patients whose antidepressants make tinnitus louder

In a new analysis, mpox does not behave like an outbreak that can be tracked only through rash, lesions, and patients who know they are sick.

Mpox control cannot wait for the outbreak to become visible

In a new analysis, mpox does not behave like an outbreak that can be tracked only through rash, lesions, and patients who know they are sick.

Neurons may not have a monopoly on how the adult brain adapts

Myelin is being pushed out of the textbook role of passive axon insulation and into the harder question of how adult brain networks adapt.

Glioblastoma may have a new immune target, but the patient test is still ahead

Preclinical work at McMaster University suggests a new drug candidate can eliminate glioblastoma tumors in models that usually resist standard treatment.

Lunar missions are starting to need their own sense of direction

Northrop Grumman is trying to turn GPS-free navigation from a mission constraint into a product category for lunar and deep-space flight.

A child’s brain may warn before focus slips

At SickKids, researchers identified a brain signal that appears before children lose attention and showed that a brief targeted intervention can restore focus.

Robot walking has to pass the wet concrete test, not just the lab floor

Researchers at Carnegie Mellon are trying to turn the precision of animal movement into models robots can actually survive outside a demo.

Cocaine addiction has no approved medicine. That is why a small psilocybin signal matters

Research published in JAMA Network Open links psilocybin plus psychotherapy with more cocaine-free days in people with cocaine use disorder.

Voice AI is leaving the demo stage for calls companies cannot afford to fumble

Vapi reached a $500 million valuation after a $50 million Series B and a win over 40 rivals for Amazon Ring.

Neurology is learning to listen for disease before symptoms take over

A new mouse study suggests that restoring an animal's own youthful gut microbiome can slow biological liver aging and reduce early cancer-linked risk signals.

The real factory test for a robot may be the dirty track beneath it

The weakest point in a robotic cell is often not the robot itself, but the linear infrastructure that has to keep moving through dust, moisture, chemicals, and temperature stress.

Mice borrowed a longevity trick from naked mole rats. That is not an anti-aging cure

Transferring a gene tied to protective hyaluronic acid production from naked mole rats into mice produced a modest but scientifically important result: the animals lived longer and showed fewer signs of biological decline.

Chronic itch may hinge on the nerve brake that stops scratching

Researchers using a chronic-itch mouse model found that TRPV4 in sensory neurons helps terminate scratching, pointing to a more precise therapeutic question than simply trying to block itch itself.

Venom and habanero offer antibiotic clues, but patients need harder proof

Mexican researchers are looking for new antimicrobial compounds in scorpion venom and habanero peppers, but the clinical story is only beginning.

The search for life on Mars has a problem: Earth may travel with it

A microbe from NASA clean rooms is not a Martian discovery. It is an Earthbound warning about how hard it is to protect the search for life.

One brain scan could give doctors more than anatomy

University of Illinois researchers demonstrated an MRI framework that measures more than 20 brain biomarkers in one scan.

For sickle cell disease, the hard question is not just cure, but who can survive the cure

The Johns Hopkins approach lowers the intensity of bone-marrow transplant conditioning, a crucial difference for patients who may not tolerate the standard path.

Pragmata finally has to beat the memory of its own trailer

Pragmata has finally climbed out of its delay capsule: IGN's review is not only a verdict on one Capcom game, but on the whole ritual of announcements that orbit players for years before landing.

Indoor solar cells are getting closer to replacing tiny batteries

The University of Queensland produced lead-free indoor perovskite solar cells with 16.36 percent efficiency.

In colorectal tumor models, alpha radiation waits until the target is marked

Pretargeted alpha therapy shows striking results in tumor models, but the clinical message must stay precise: this is not yet proof of a human therapy.

An AI model passed the diagnosis test. Medicine still has to decide what that means

An OpenAI model beat doctors in a diagnosis test, but medicine is not a leaderboard.

AI models are getting a debugger, but the black box is not solved

Goodfire released Silico, a mechanistic-interpretability tool that moves LLM debugging into the training process itself.

One protein shows how growing brains tell neurons when to stop or move on

Ten4 guides neuron migration by switching between adhesion and repulsion in the developing brain.

The petri dish did not become a gamer. It learned the rule.

UC Santa Cruz researchers trained brain organoids using electronic signals, boosting their success rate from 4.5% to 46%.

Depression’s next clue is cellular: neurons and microglia move to center stage

The discovery focused on excitatory neurons and microglia, revealing disrupted circuits in donated brain tissue from 26 donors with depression.

AI could make solar site checks faster, but every shadow still needs proof

The new method tries to replace part of costly urban modeling with one panoramic image and a neural estimate.

MDGA1 mutation offers clue to male autism bias

A study in *EMBO Molecular Medicine* links MDGA1 gene mutations to autism’s male bias, marking a step toward biological clarity—but no treatment yet.

Same neurons fire for seeing and imagining objects

Electrodes in epilepsy patients revealed identical brain activity for seeing and imagining objects.

AI Model Links Mental Health

Anglia Ruskin University led the research, which involved collaboration with Cranfield University, the University of Portsmouth, and Intelligent Omics Ltd.

SymptomWise: The AI diagnostic tool that actually admits its limits

SymptomWise’s authors didn’t just build an AI diagnostic tool—they designed it to fail gracefully, a rarity in a field where overconfidence is the default setting.

How gut inflammation rewires the ‘second brain’—and why it lasts

Enteric glial cells—not immune cells—may hold the key to why 30% of IBD patients develop chronic motility disorders post-recovery.

The brain’s ‘stop eating’ switch isn’t where we thought

Mouse studies at the German Research Center for Environmental Health reveal astrocytes—once dismissed as neuronal scaffolding—directly activate the brain’s fullness neurons via a glucose-triggered relay.

Google’s offline AI dictation is a quiet test for edge computing

Gemma’s 2B-parameter model now powers a dictation app that transcribes speech without pinging a single server.

Depression’s hidden toll: Sleep, not weight, may drive diabetes risk

Disrupted sleep in depressed young adults predicted insulin resistance more accurately than weight gain in a 10-year Australian study of 1,900 participants.

0.5-micrometer robots with no brain—just physics and hype

Leiden’s new microrobots ditch brains for *asymmetric hydrodynamics*—a trick that lets 0.5-micrometer blobs pretend to be autonomous, so long as the lab keeps the fluids flowing just right.

Calcium channel flaws rewrite early epilepsy risk story

The mutations don’t just predict epilepsy—they rewire the brain’s blueprint during the second trimester, according to Baylor’s *Neuron* paper.

APOE4’s early brain disruption—before memory fades

APOE4 carriers—roughly 1 in 4 people globally—may experience altered brain activity in their 30s, decades before Alzheimer’s symptoms emerge.

Pollution and inequality may age your brain faster—here’s the evidence

Brain scans from 34 countries reveal that air pollution and socioeconomic inequality can widen the gap between biological and chronological brain age by up to two years.

Social ties vs. pollution: How your environment ages your brain

Researchers analyzing 34 countries’ exposome data pinpointed two distinct drivers of brain aging: social interactions speed cognitive decline, while pollutants erode structural integrity.

Penicillin allergy labels are wrong for 90% of patients—new study

Professor Jason Trubiano’s team just confirmed what clinicians suspected: **90% of hospital patients labeled ‘penicillin-allergic’ test negative** when properly evaluated.

AI Diagnostics Reach Bengaluru’s Underserved Clinics

A Bengaluru-based engineer’s AI tool cuts mental health screening time by 60% in understaffed clinics.

Visual Perception Model Confirmed

Researchers at TUM have settled a six-decade dispute regarding fundamental mechanisms of visual perception in mammals.

Scalable sensors slash cost of brain disorder research

A preprint study shows new sensors recording neural activity in brain organoids for under $500 per unit, but clinical relevance is years away.

Chronic pain’s neural map: A precise target, not a cure

Nearly a dozen personalized cancer vaccine platforms are now in human trials, but none have cleared regulatory approval.

BrainOS Clean 2.0 promises less training, but reality still wins

SelfPath AI in BrainOS Clean 2.0 promises Tennant robots autonomous route adaptation, but there are no clear performance numbers for chaotic industrial settings.

HIV in 2024: Progress, but no victory yet

Antiretroviral therapy now extends near-normal lifespans in wealthy nations, yet 60% of new HIV infections still occur in sub-Saharan Africa.

Viagra’s hidden potential: A rare disease’s unexpected ally

A drug originally designed for erectile dysfunction now shows **unexpected muscle-strengthening effects** in children with a fatal neurological disorder.

Muscles Turned Motors

Researchers are exploring a new technology that involves turning muscles into motors to treat spinal cord injuries and Crohn's disease.

Lab-grown retinas reveal how cones fight degeneration—with limits

Twenty thousand lab-grown human retinas—each a cluster of cells no wider than a sesame seed—just rewrote a key chapter in how cone photoreceptors resist degeneration.

Brain atlas maps human growth—but gaps remain

A team led by neuroscientists at the University of Pennsylvania has compiled the most detailed map yet of brain connectivity across nine decades of life.

Sleep EEG patterns may quietly predict dementia risk—with limits

A 2023 *Nature Aging* study analyzing sleep EEGs from 10,000+ adults found subtle brainwave patterns that correlated with accelerated biological aging and future dementia risk.

Stroke sparks brain’s hidden rejuvenation effect

A study of 523 stroke survivors reveals the brain’s undamaged side may temporarily ‘de-age’ to compensate for injury—but the implications for recovery remain unclear.

Gene therapy silences pain at its source—without opioids

Dr. James White, MD, found a clear benefit to using the 4D model to target treatment for CRT patients.

Smart crane trucks: more precision, but more service too

Liebherr and Konecranes are adding autonomous systems to crane trucks, but the field is a very different environment.

Parkinson’s clue: A faulty ‘overflow valve’ in cells

The hunt for Parkinson’s disease mechanisms just got a new lead: a cellular ‘overflow valve’ that, when broken, may let toxins accumulate.

Fear’s fading grip: How the brain recalibrates threat

Optogenetic mapping in 24 mice revealed a neural feedback loop between the amygdala and prefrontal cortex that adjusts fear responses in real time.

Droughts may fuel antibiotic resistance—but the link is hazy

Meta’s legal gamble: When tech giants bet on inevitability

A federal judge rejected Meta’s argument that child harm is an unavoidable cost of operating at scale—setting a precedent for two more trials.

Dopamine’s ‘blink of an eye’ timing—what the brain study really shows

Neuroscientists have now measured dopamine’s influence on brain activity in intervals as brief as 100 milliseconds—faster than a human blink.

Why this lung cancer returns—and why inflammation may be key

Scientists identify 95% fatality rate for small cell lung cancer patients.

A 30-million-cell atlas of the human brain—with limits

CAR-T in the body: A cautious step for myeloma patients

MSKCC's in vivo CAR-T trial shows promise for 5 myeloma patients.

Why overactive brains may trigger falls in aging

A recent study suggests the brain’s overreaction to minor disturbances may contribute to falls in older adults and Parkinson’s patients.

Neuralink’s gaming test is a real workflow shift—not sci-fi

Neuralink’s first public gaming demo proves brain implants can handle complex inputs—but reliability remains untested.

Parkinson’s trial shows promise—but not a cure

BIIB094’s phase 1 trial marks the first time an antisense oligonucleotide has successfully targeted LRRK2 in Parkinson’s patients.

Alzheimer’s ‘death switch’: The mouse study hype filter

Alzheimer’s ‘death switch’ in mice slows plaque buildup—but human trials remain years away.

Glioblastoma’s hidden driver: CD47’s new role beyond immunity

Australia's Centre for Cancer Biology exposed CD47 as glioblastoma's growth engine, not just an immune shield, yet clinical translation stays distant.

A brainstem link to hypertension—what the evidence really shows

Deactivating a brainstem region tied to coughing/laughing in rodents normalized blood pressure—hinting at hypertension’s overlooked neural switch.

Exercise may rewire brains scarred by childhood trauma

Childhood trauma scars the brain—but 150+ minutes of weekly exercise may rewire its stress circuits, study finds.

How neuron groups shape memory—what we know

Neuroscientists identify synchronized neuron clusters—engrams—as the likely physical basis of memory, but evidence remains observational and limited to anima...

Blood Marker Shows Promise Predicting Post-Arrest Cognition

Blood test for NfL protein predicts post-cardiac-arrest cognitive decline with 84% accuracy in ESC 2026 study.

AI finds no brain structure link to navigation skills—so what does?

AI debunks decades of neuroscience dogma: London cabbies’ legendary nav skills don’t come from distinctive brain anatomy.

New Dopamine Signal Found in Mouse Brain Study

Boston University team finds dopamine signal in mice that encodes movement direction—rewriting how we link vision to action.

Autism nitric oxide findings are interesting - not final

A new study links nitric oxide to mTOR overactivation in a subset of autism cases.

A Schizophrenia Biomarker—But How Close to Treatment?

Human biomarker study flags overactive brain circuits as a schizophrenia drug target—but clinical use remains a decade away.

AI-built ‘intrabodies’ target Alzheimer’s—with cautious optimism

AI-designed antibody fragments, small enough to be produced inside human cells, have shown potential to neutralize proteins tied to Alzheimer’s and MND—though only in lab models so far.

Nerve implants decode leg movement, offering hope for natural prosthetics

Swedish researchers have translated nerve signals into leg movement commands, including toe wiggling, in a first for above-knee amputees.

A heart digital twin saved the surgery, but raised a bigger question

A Boston surgical team rehearsed a high-risk pediatric procedure on a digital twin of the patient’s heart before making the first incision.

Lecanemab's Mechanism Revealed

Lecanemab, a key Alzheimer's drug, has been found to activate immune cells through the Fc fragment of the antibody, according to researchers.

Google is turning old news archives into flood warnings where sensors are missing

Instead of radar and hydrological stations, Google's latest flood prediction model mines archived newspaper reports from the 1980s.

AI pulled video from a mouse brain, but the bigger test is what animals actually see

University College London scientists have reconstructed video purely from mouse neural activity, using visual-cortex electrodes and a dynamic deep-learning model—no external camera needed.

A genetic flaw in early brain wiring opens a new map of hard-to-treat epilepsy

Gene mutations disrupt cortical layer formation in early brain development.

LRG1 protein: A precise target for diabetic blindness prevention

LRG1, a protein previously linked to blood vessel formation, now stands accused of starving retinal cells in diabetic mice by constricting their microvasculature.

Japan’s Parkinson’s cell therapy now faces the test approval cannot answer

A stem-cell therapy for Parkinson’s disease crosses an important regulatory threshold in Japan, but this is not a moment for miracle language.

Alibaba loses its AI brain trust in silent coup

Alibaba Cloud’s entire Qwen development team has resigned following an internal reorganization, leaving China’s most ambitious open-source LLM in limbo.

A Dravet therapy is testing a shift from seizure control to the gene

Zorevunersen reduced seizures by up to 91 percent in early trials involving children with Dravet syndrome.

Two hand photos could shorten the search for a rare hormone disorder

Kobe University's system needs only two photos: dorsal hand view and clenched fist.

NeurOSmart: When Robot Brains Meet Real Factory Floors

Fraunhofer’s NeurOSmart project pairs neuromorphic chips with LIDAR to make human-robot work safer, but industrial proof is still ahead.